Laparoscopic evaluation and management of adnexal masses and ovarian cancer

Farr R. Nezhat, Jason Sternchos, Tamara Finger, Tanja Pejovic

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Introduction The American Cancer Society estimates that 21,990 women will be diagnosed with ovarian cancer and 15,460 will die of the disease in 2011 [1]. Of these 21,990 patients, 20% will have stage I disease, for which 5-year survival rates approach 90%. However, numerous studies have shown that a significant percentage of patients with apparent early stage (stage I) ovarian cancer actually harbor microscopic metastatic disease. Consequently, the benefits of surgical staging for epithelial ovarian carcinoma have been well established. Traditionally, it has been recommended that a comprehensive surgical staging procedure for epithelial ovarian and fallopian tube cancers include a total abdominal hysterectomy, bilateral salpingo-oophorectomy, peritoneal cytologic washings, biopsies of adhesions and peritoneal surfaces, omentectomy, and retroperitoneal lymph node sampling from the pelvic and para-aortic regions through a generous vertical midline laparotomy incision [2]. With the advent of minimally invasive surgical techniques, surgeons are now able to perform all of the necessary procedures for comprehensive surgical staging, including pelvic and para-aortic lymphadenectomies and omentectomies, using conventional videolaparoscopy or robotic-assisted videolaparoscopy in selected patients.

Original languageEnglish (US)
Title of host publicationAltchek's Diagnosis and Management of Ovarian Disorders, Third Edition
PublisherCambridge University Press
Pages381-403
Number of pages23
ISBN (Electronic)9781139003254
ISBN (Print)9781107012813
DOIs
StatePublished - Jan 1 2010

Fingerprint

Ovarian Neoplasms
Fallopian Tube Neoplasms
Robotics
Ovariectomy
Lymph Node Excision
Hysterectomy
Laparotomy
Survival Rate
Lymph Nodes
Carcinoma
Biopsy
Surgeons

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Nezhat, F. R., Sternchos, J., Finger, T., & Pejovic, T. (2010). Laparoscopic evaluation and management of adnexal masses and ovarian cancer. In Altchek's Diagnosis and Management of Ovarian Disorders, Third Edition (pp. 381-403). Cambridge University Press. https://doi.org/10.1017/CBO9781139003254.025

Laparoscopic evaluation and management of adnexal masses and ovarian cancer. / Nezhat, Farr R.; Sternchos, Jason; Finger, Tamara; Pejovic, Tanja.

Altchek's Diagnosis and Management of Ovarian Disorders, Third Edition. Cambridge University Press, 2010. p. 381-403.

Research output: Chapter in Book/Report/Conference proceedingChapter

Nezhat, FR, Sternchos, J, Finger, T & Pejovic, T 2010, Laparoscopic evaluation and management of adnexal masses and ovarian cancer. in Altchek's Diagnosis and Management of Ovarian Disorders, Third Edition. Cambridge University Press, pp. 381-403. https://doi.org/10.1017/CBO9781139003254.025
Nezhat FR, Sternchos J, Finger T, Pejovic T. Laparoscopic evaluation and management of adnexal masses and ovarian cancer. In Altchek's Diagnosis and Management of Ovarian Disorders, Third Edition. Cambridge University Press. 2010. p. 381-403 https://doi.org/10.1017/CBO9781139003254.025
Nezhat, Farr R. ; Sternchos, Jason ; Finger, Tamara ; Pejovic, Tanja. / Laparoscopic evaluation and management of adnexal masses and ovarian cancer. Altchek's Diagnosis and Management of Ovarian Disorders, Third Edition. Cambridge University Press, 2010. pp. 381-403
@inbook{46b5e9ef5ad7402eba46f6e2898ea6bc,
title = "Laparoscopic evaluation and management of adnexal masses and ovarian cancer",
abstract = "Introduction The American Cancer Society estimates that 21,990 women will be diagnosed with ovarian cancer and 15,460 will die of the disease in 2011 [1]. Of these 21,990 patients, 20{\%} will have stage I disease, for which 5-year survival rates approach 90{\%}. However, numerous studies have shown that a significant percentage of patients with apparent early stage (stage I) ovarian cancer actually harbor microscopic metastatic disease. Consequently, the benefits of surgical staging for epithelial ovarian carcinoma have been well established. Traditionally, it has been recommended that a comprehensive surgical staging procedure for epithelial ovarian and fallopian tube cancers include a total abdominal hysterectomy, bilateral salpingo-oophorectomy, peritoneal cytologic washings, biopsies of adhesions and peritoneal surfaces, omentectomy, and retroperitoneal lymph node sampling from the pelvic and para-aortic regions through a generous vertical midline laparotomy incision [2]. With the advent of minimally invasive surgical techniques, surgeons are now able to perform all of the necessary procedures for comprehensive surgical staging, including pelvic and para-aortic lymphadenectomies and omentectomies, using conventional videolaparoscopy or robotic-assisted videolaparoscopy in selected patients.",
author = "Nezhat, {Farr R.} and Jason Sternchos and Tamara Finger and Tanja Pejovic",
year = "2010",
month = "1",
day = "1",
doi = "10.1017/CBO9781139003254.025",
language = "English (US)",
isbn = "9781107012813",
pages = "381--403",
booktitle = "Altchek's Diagnosis and Management of Ovarian Disorders, Third Edition",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Laparoscopic evaluation and management of adnexal masses and ovarian cancer

AU - Nezhat, Farr R.

AU - Sternchos, Jason

AU - Finger, Tamara

AU - Pejovic, Tanja

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Introduction The American Cancer Society estimates that 21,990 women will be diagnosed with ovarian cancer and 15,460 will die of the disease in 2011 [1]. Of these 21,990 patients, 20% will have stage I disease, for which 5-year survival rates approach 90%. However, numerous studies have shown that a significant percentage of patients with apparent early stage (stage I) ovarian cancer actually harbor microscopic metastatic disease. Consequently, the benefits of surgical staging for epithelial ovarian carcinoma have been well established. Traditionally, it has been recommended that a comprehensive surgical staging procedure for epithelial ovarian and fallopian tube cancers include a total abdominal hysterectomy, bilateral salpingo-oophorectomy, peritoneal cytologic washings, biopsies of adhesions and peritoneal surfaces, omentectomy, and retroperitoneal lymph node sampling from the pelvic and para-aortic regions through a generous vertical midline laparotomy incision [2]. With the advent of minimally invasive surgical techniques, surgeons are now able to perform all of the necessary procedures for comprehensive surgical staging, including pelvic and para-aortic lymphadenectomies and omentectomies, using conventional videolaparoscopy or robotic-assisted videolaparoscopy in selected patients.

AB - Introduction The American Cancer Society estimates that 21,990 women will be diagnosed with ovarian cancer and 15,460 will die of the disease in 2011 [1]. Of these 21,990 patients, 20% will have stage I disease, for which 5-year survival rates approach 90%. However, numerous studies have shown that a significant percentage of patients with apparent early stage (stage I) ovarian cancer actually harbor microscopic metastatic disease. Consequently, the benefits of surgical staging for epithelial ovarian carcinoma have been well established. Traditionally, it has been recommended that a comprehensive surgical staging procedure for epithelial ovarian and fallopian tube cancers include a total abdominal hysterectomy, bilateral salpingo-oophorectomy, peritoneal cytologic washings, biopsies of adhesions and peritoneal surfaces, omentectomy, and retroperitoneal lymph node sampling from the pelvic and para-aortic regions through a generous vertical midline laparotomy incision [2]. With the advent of minimally invasive surgical techniques, surgeons are now able to perform all of the necessary procedures for comprehensive surgical staging, including pelvic and para-aortic lymphadenectomies and omentectomies, using conventional videolaparoscopy or robotic-assisted videolaparoscopy in selected patients.

UR - http://www.scopus.com/inward/record.url?scp=85010471696&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010471696&partnerID=8YFLogxK

U2 - 10.1017/CBO9781139003254.025

DO - 10.1017/CBO9781139003254.025

M3 - Chapter

AN - SCOPUS:85010471696

SN - 9781107012813

SP - 381

EP - 403

BT - Altchek's Diagnosis and Management of Ovarian Disorders, Third Edition

PB - Cambridge University Press

ER -